IFP Advisors’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.55K | Sell |
114
-16
| -12% | -$1.03K | ﹤0.01% | 3495 |
|
|
2026
Q1 | $7.33K | Sell |
130
-18
| -12% | -$1.17K | ﹤0.01% | 3322 |
|
|
2025
Q4 | $11.9K | Buy |
148
+68
| +85% | +$4.57K | ﹤0.01% | 2969 |
|
|
2025
Q3 | $3.9K | Buy |
+80
| New | +$4.95K | ﹤0.01% | 3383 |
|
|
2025
Q2 | – | Sell |
-10
| Closed | -$662 | – | 3457 |
|
|
2025
Q1 | $636 | Sell |
10
-3
| -23% | -$204 | ﹤0.01% | 3412 |
|
|
2024
Q4 | $1.01K | Buy |
13
+3
| +30% | +$241 | ﹤0.01% | 3275 |
|
|
2024
Q3 | $804 | Hold |
10
| – | – | ﹤0.01% | 3101 |
|
|
2024
Q2 | $827 | Hold |
10
| – | – | ﹤0.01% | 3021 |
|
|
2024
Q1 | $854 | Hold |
10
| – | – | ﹤0.01% | 2884 |
|
|
2023
Q4 | $855 | Hold |
10
| – | – | ﹤0.01% | 2828 |
|
|
2023
Q3 | $896 | Sell |
10
-203
| -95% | -$18.1K | ﹤0.01% | 3022 |
|
|
2023
Q2 | $18.1K | Sell |
213
-84
| -28% | -$7.1K | ﹤0.01% | 2053 |
|
|
2023
Q1 | $27K | Buy |
297
+47
| +19% | +$3.81K | ﹤0.01% | 1887 |
|
|
2022
Q4 | $26K | Buy |
250
+16
| +7% | +$1.29K | ﹤0.01% | 2689 |
|
|
2022
Q3 | $24K | Buy |
234
+8
| +4% | +$574 | ﹤0.01% | 2917 |
|
|
2022
Q2 | $21K | Hold |
226
| – | – | ﹤0.01% | 2793 |
|
|
2022
Q1 | $21K | Buy |
+226
| New | +$12.3K | ﹤0.01% | 2793 |
|
|
2021
Q1 | – | Sell |
-530
| Closed | -$65.6K | – | 3089 |
|
|
2020
Q4 | $62K | Buy |
530
+446
| +531% | +$48K | ﹤0.01% | 1348 |
|
|
2020
Q3 | $7K | Buy |
84
+52
| +163% | +$4.54K | ﹤0.01% | 2037 |
|
|
2020
Q2 | $3K | Buy |
32
+10
| +45% | +$1.01K | ﹤0.01% | 2265 |
|
|
2020
Q1 | $3K | Buy |
+22
| New | +$2.39K | ﹤0.01% | 2246 |
|
|
2019
Q4 | – | Sell |
-26
| Closed | -$3.15K | – | 2952 |
|
|
2019
Q3 | $3K | Buy |
+26
| New | +$3.3K | ﹤0.01% | 2539 |
|
|
2019
Q1 | $3K | Buy |
41
+29
| +242% | +$2.64K | ﹤0.01% | 2006 |
|
|
2018
Q4 | $1K | Sell |
12
-101
| -89% | -$10.6K | ﹤0.01% | 3310 |
|
|
2018
Q3 | $13K | Sell |
113
-123
| -52% | -$12.7K | ﹤0.01% | 2696 |
|
|
2018
Q2 | $21K | Sell |
236
-151
| -39% | -$12.8K | ﹤0.01% | 2431 |
|
|
2018
Q1 | $22K | Hold |
387
| – | – | ﹤0.01% | 2321 |
|
|
2017
Q4 | $22K | Hold |
387
| – | – | ﹤0.01% | 2354 |
|
|
2017
Q3 | $17K | Hold |
387
| – | – | ﹤0.01% | 2705 |
|
|
2017
Q2 | $15K | Buy |
387
+266
| +220% | +$10.9K | ﹤0.01% | 2752 |
|
|
2017
Q1 | $5K | Hold |
121
| – | – | ﹤0.01% | 3287 |
|
|
2016
Q4 | $5K | Sell |
121
-14
| -10% | -$528 | ﹤0.01% | 3291 |
|
|
2016
Q3 | $5K | Buy |
135
+108
| +400% | +$3.71K | ﹤0.01% | 3227 |
|
|
2016
Q2 | $1K | Sell |
27
-14
| -34% | -$423 | ﹤0.01% | 3624 |
|
|
2016
Q1 | $3K | Buy |
41
+14
| +52% | +$452 | ﹤0.01% | 2003 |
|
|
2015
Q4 | $1K | Buy |
+27
| New | +$876 | ﹤0.01% | 3520 |
|
Other funds holding HAE
AI
IFP Advisors's HAE Position: Q2 2026 in Review
IFP Advisors reduced its Haemonetics (HAE) stake by 12% in Q2 2026, selling an estimated $1.03K and leaving 114 shares worth $8.55K. The position accounts for ﹤0.01% of the portfolio, ranked #3495.
IFP Advisors first reported a position in HAE in Q4 2015 and has held it in 36 quarters since. The position peaked at $62K in Q4 2020. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- IFP Advisors held 114 shares of Haemonetics worth $8.55K as of Q2 2026.
- IFP Advisors sold 16 Haemonetics shares in Q2 2026, an estimated $1.03K.
- Haemonetics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3495 holding.
- IFP Advisors first reported a position in Haemonetics in Q4 2015 and has held it in 36 quarters since.
- IFP Advisors's Haemonetics position peaked at $62K in Q4 2020.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.